Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03927885
PHASE2/PHASE3

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This phase II/III trial studies an open labeled placebo to see how well it works compared with waitlist control in reducing cancer related fatigue in patients with cancer that has spread to other places in the body. A placebo is not a drug and is not designed to treat any disease or illness. Recent studies have found that cancer related fatigue symptoms in cancer survivors are improved with open labeled placebo (that is, patients know they are taking a placebo). It is not yet known how well an open labeled placebo works when compared with waitlist control in reducing cancer related fatigue.

Official title: Open Labeled Placebo for Treatment of Cancer Related Fatigue in Patients With Advanced Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2019-03-30

Completion Date

2026-12-31

Last Updated

2026-02-19

Healthy Volunteers

No

Interventions

OTHER

Placebo Administration

Given open labeled placebo PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Waiting List

Assigned to a waiting list

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States